H. Hemming et al., LIVER-TUMOR PROMOTING ACTIVITY OF 3,4,5,3',4'-PENTACHLOROBIPHENYL ANDITS INTERACTION WITH 2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN, European journal of pharmacology. Environmental toxicology and pharmacology section, 292(3-4), 1995, pp. 241-249
This study was undertaken to compare the tumour promoting effects indu
ced by 3,4,5,3',4'-pentachlorobiphenyl (PCB 126) and 2,3,7,8-tetrachlo
rodibenzo-p-dioxin (TCDD). In addition, interactive effects in rats tr
eated with combinations of PCB 126 and TCDD were studied. Partially he
patectomized female Sprague-Dawley rats were initiated with nitrosodie
thylamin. After 5 weeks of recovery the promotion treatment started an
d continued for 20 weeks. The results from the present study demonstra
te that PCB 126 elicit approximately 10% of TCDD's tumour promoting ac
tivity measured as enhancement of the development of gamma-glutamyl-tr
anspeptidase-positive altered hepatic foci in the liver. The factor re
quired for the PCB to match the response of TCDD was adopted as a toxi
c equivalency factor and was in this case 0.1, which is the same as th
e factor suggested by Ahlborg et al. (1994). In the groups treated wit
h a mixture of PCB 126 and TCDD the tumour promoting effect indicated
an additive response. This result suggests that PCB 126 and TCDD act b
y the same mechanistical pathway, which in turn, supports that the tox
ic equivalency factor-concept can be used for TCDD-like tumour promote
rs.